Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Conditions

Breast Neoplasms 51Neoplasms 34Colorectal Neoplasms 23Lung Neoplasms 17Prostatic Neoplasms 16Melanoma 15Neoplastic Cells, Circulating 13Pancreatic Neoplasms 11Multiple Myeloma 11Uterine Cervical Neoplasms 10Ovarian Neoplasms 10Carcinoma, Non-Small-Cell Lung 8Papillomavirus Infections 7Neoplasm Metastasis 7Leukemia, Myeloid, Acute 7Colonic Neoplasms 7Lymphoma, Follicular 6Lymphoma 6Hematologic Neoplasms 6Uveal Melanoma 5Sarcoma 5Head and Neck Neoplasms 5Glioma 5Uterine Cervical Dysplasia 4Urinary Bladder Neoplasms 4Rectal Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Glioblastoma 4Disease 4COVID-19 4

Interventions

Valganciclovir 2Blood Specimen Collection 2letermovir 1Zidovudine 1Valacyclovir 1VCL-CB01 vaccine 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Immunologic Techniques 1Gene-Eden-VIR 1Ganciclovir 1Flow Cytometry 1Acyclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Cytomegalovirus Infections × Blood Specimen Collection × Clear all
NCT04017962 2025-08-11

A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
102 enrolled 13 charts

Cytomegalovirus Infections

NCT02600065 2023-02-16

GLIO-CMV-01

University of Erlangen-Nürnberg Medical School

Completed
350 enrolled

Cytomegalovirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡